Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study)

OBJECTIVE: To assess efficacy and tolerance of EGFR tyrosine-kinase inhibitors (TKIs) for advanced EGFR-mutated non-small cell lung cancer (NSCLC) in octogenarians. PATIENTS AND METHODS: Patients aged 80 years or older with EGFR-mutated NSCLC treated by EGFR TKI between January 2011 and March 2015 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Corre, Romain, Gervais, Radj, Guisier, Florian, Tassy, Louis, Vinas, Florent, Lamy, Régine, Fraboulet, Gislaine, Greillier, Laurent, Doubre, Helene, Descourt, Renaud, Chouaid, Christos, Auliac, Jean-Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper: Gerotarget (Focus on Aging)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823568/
https://www.ncbi.nlm.nih.gov/pubmed/29492192
http://dx.doi.org/10.18632/oncotarget.23836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823568/
https://www.ncbi.nlm.nih.gov/pubmed/29492192
http://dx.doi.org/10.18632/oncotarget.23836

Ejemplares similares